Founded as spin-off of the University of Modena and Reggio Emilia, Rigenerand develops and produces biomedical technology to empower cell culture combining the need of high yield with innovative biocompatible materials.
Their unique bioreactor platform defined as Integrated Space Optimized Culture-System (ISOCULT) has been developed to support 3D tissue-like cultures to amplify human cells starting from either cell lines or primary collected cells from patients, including cancer cells and stem cells. The ISOCULT technology provides different solutions. Among them, VITVO has been developed for early preclinical prediction of drug efficacy and toxicity in term of enhanced reliability versus animal model and to improve prediction versus 2D miniaturized systems.
More information >>
All Rigenerand Products
.
